Phase 1/2 Study of a Plant-Based Seasonal Recombinant Trivalent VLP Influenza Vaccine

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Influenza

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
Study leads
  • Brian Ward, MD

    Study Chair

    McGill University